KLF4 and breast carcinoma: Results from further clonogenic assay showed that depletion of KLF4 in breast cancer cells significantly enhanced that efficacy of olaparib and other chemotherapy agents such as doxorubicin and cisplatin in killing cancer cells (Fig 7O–R).